Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting lipid-protein interaction to treat Syk-mediated acute myeloid leukemia.
Singaram I, Sharma A, Pant S, Lihan M, Park MJ, Pergande M, Buwaneka P, Hu Y, Mahmud N, Kim YM, Cologna S, Gevorgyan V, Khan I, Tajkhorshid E, Cho W. Singaram I, et al. Among authors: mahmud n. Nat Chem Biol. 2023 Feb;19(2):239-250. doi: 10.1038/s41589-022-01150-z. Epub 2022 Oct 13. Nat Chem Biol. 2023. PMID: 36229686 Free PMC article.
FOXM1 contributes to treatment failure in acute myeloid leukemia.
Khan I, Halasi M, Patel A, Schultz R, Kalakota N, Chen YH, Aardsma N, Liu L, Crispino JD, Mahmud N, Frankfurt O, Gartel AL. Khan I, et al. Among authors: mahmud n. JCI Insight. 2018 Aug 9;3(15):e121583. doi: 10.1172/jci.insight.121583. eCollection 2018 Aug 9. JCI Insight. 2018. PMID: 30089730 Free PMC article.
Nuclear FOXM1 drives chemoresistance in AML.
Khan I, Halasi M, Zia MF, Gann P, Gaitonde S, Mahmud N, Gartel AL. Khan I, et al. Among authors: mahmud n. Leukemia. 2017 Jan;31(1):251-255. doi: 10.1038/leu.2016.270. Epub 2016 Oct 3. Leukemia. 2017. PMID: 27694928 No abstract available.
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma.
Patel P, Oh AL, Koshy M, Sweiss K, Saraf SL, Quigley JG, Khan I, Mahmud N, Hacker E, Ozer H, Peace DJ, Weichselbaum RR, Aydogan B, Rondelli D. Patel P, et al. Among authors: mahmud n. Leuk Lymphoma. 2018 Jul;59(7):1666-1671. doi: 10.1080/10428194.2017.1390231. Epub 2017 Oct 25. Leuk Lymphoma. 2018. PMID: 29065747 Clinical Trial.
Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study.
Patel P, Aydogan B, Koshy M, Mahmud D, Oh A, Saraf SL, Quigley JG, Khan I, Sweiss K, Mahmud N, Peace DJ, DeMasi V, Awan AM, Weichselbaum RR, Rondelli D. Patel P, et al. Among authors: mahmud d, mahmud n. Biol Blood Marrow Transplant. 2014 Dec;20(12):2034-41. doi: 10.1016/j.bbmt.2014.09.005. Epub 2014 Sep 16. Biol Blood Marrow Transplant. 2014. PMID: 25234438 Free article. Clinical Trial.
Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease.
Saraf SL, Oh AL, Patel PR, Sweiss K, Koshy M, Campbell-Lee S, Gowhari M, Jain S, Peace D, Quigley JG, Khan I, Molokie RE, Mahmud N, Gordeuk VR, Rondelli D. Saraf SL, et al. Among authors: mahmud n. Biol Blood Marrow Transplant. 2018 Aug;24(8):1759-1765. doi: 10.1016/j.bbmt.2018.03.031. Epub 2018 Apr 12. Biol Blood Marrow Transplant. 2018. PMID: 29656137 Free PMC article.
Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease.
Saraf SL, Oh AL, Patel PR, Jalundhwala Y, Sweiss K, Koshy M, Campbell-Lee S, Gowhari M, Hassan J, Peace D, Quigley JG, Khan I, Molokie RE, Hsu LL, Mahmud N, Levinson DJ, Pickard AS, Garcia JG, Gordeuk VR, Rondelli D. Saraf SL, et al. Among authors: mahmud n. Biol Blood Marrow Transplant. 2016 Mar;22(3):441-8. doi: 10.1016/j.bbmt.2015.08.036. Epub 2015 Sep 5. Biol Blood Marrow Transplant. 2016. PMID: 26348889 Free article. Clinical Trial.
375 results